2009
DOI: 10.1210/jc.2008-2005
|View full text |Cite
|
Sign up to set email alerts
|

Role of Follistatin in Promoting Adipogenesis in Women

Abstract: Follistatin is a new adipokine important for adipogenesis. Down-regulated WAT expression of follistatin in obesity may counteract adiposity but could, by inhibiting adipogenesis, contribute to hypertrophic obesity (large fat cells) and insulin resistance.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
47
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 55 publications
(49 citation statements)
references
References 34 publications
2
47
0
Order By: Relevance
“…Notably, this human study did not evaluate follistatin expression in adipose tissues which is one tissue in which follistatin gene was expressed in the current study. More recently, follistatin gene expression has been detected in human adipose tissues with greater expression noted in subcutaneous as opposed to visceral adipose depots [52]. These data agree with the findings of the current study where follistatin expression was notably minimal in omental and mesenteric depots, in marked contrast to the clear expression noted in the other adipose tissue depots studied.…”
Section: Discussionsupporting
confidence: 92%
“…Notably, this human study did not evaluate follistatin expression in adipose tissues which is one tissue in which follistatin gene was expressed in the current study. More recently, follistatin gene expression has been detected in human adipose tissues with greater expression noted in subcutaneous as opposed to visceral adipose depots [52]. These data agree with the findings of the current study where follistatin expression was notably minimal in omental and mesenteric depots, in marked contrast to the clear expression noted in the other adipose tissue depots studied.…”
Section: Discussionsupporting
confidence: 92%
“…However, EE-CA and PioFluMet had divergent effects on markers such as circulating CRP, leptin, HMW adiponectin, cholesterol, and triglycerides, and on carotid IMT, lean mass, and visceral hepatic adiposity, all these divergences favoring treatment with PioFluMet. The circulating levels of follistatin, a gly- coprotein that promotes adipogenesis in women (20), were elevated on EE-CA but normal on PioFluMet. Safety markers such as ALT and AST evolved also in a direction that was more reassuring for PioFluMet.…”
Section: Discussionmentioning
confidence: 99%
“…Thus, skeletal muscle does not seem to secrete follistatin to any significant extent. In cultured white adipose tissue, follistatin is secreted into the media, suggesting a potential contribution to systemic levels (35). However, while follistatin gene expression is markedly doi: 10.1210/jc.2015-3668 press.endocrine.org/journal/jcem 555 increased in the liver in response to exercise in mice (11), no increase was detected in tissues such as adipose tissue, muscle, heart, kidney, and spleen (11).…”
Section: Origin Of Circulating Follistatin In Manmentioning
confidence: 99%